Table 1. Subject disposition (all randomized subjects).

	4-mg fine granules (N = 24)	4-mg tablet (N = 24)
Treated, n (%)	24 (100)	21 (87.5)
Completed the study, n (%)	24 (100)	21 (87.5)
Discontinued from the study, n (%)	0	3 (12.5)
Discontinued before study treatment in treatment period 2, n	0	3
Primary reason for discontinuation, n (%)
Othera	0	3 (12.5)

^aReasons for discontinuations from study were: increased lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase (n = 1); pyrexia (n = 1); and increased white blood cell count (n = 1).